We recently published a list of 10 Best Medical Stocks to Buy Now. In this article, we are going to take a look at where ...

The antibody drug conjugate didn’t help patients live longer in a confirmatory trial, prompting a review of its conditional ...

Gilead Sciences said on Friday it was voluntarily withdrawing the U.S. approval for Trodelvy in previously treated patients ...

We recently compiled a list of 10 Most Promising Long-Term Stocks According to Hedge Funds. In this article, we will look at ...

It may soon be possible to determine which patients with a type of liver cancer called hepatocellular carcinoma would benefit from immunotherapy, according to a preclinical study by Weill Cornell ...

Currently, there are a few available treatment options for liver cancer, including a combination of immunotherapies and a class of drugs known as tyrosine kinase inhibitors (TKIs), but their long-term ...

German science and technology group Merck is open to more acquisitions for its Life Science business after announcing in May ...

German science and technology giant Merck on Thursday said it is confident of returning to medium-term growth after a ...

Merck also changed the outlook for its Healthcare business to "slight growth", compared to a previously expected ...

Kulkarni's colorectal cancer was Stage 4. “That’s when the ground fell out from beneath me, basically. And I will never forget that feeling. But I will tell you that was the one day that I ...

Drug makers Exelixis, Inc. (EXEL) and Merck & Co Inc.(MRK) announced Monday that they have entered into a clinical development ...